Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yan Xu
Institution:
Hubei University of Science and Technology
Observed institutions:
Hubei University of Science and Technology,
Gannan Medical University,
First Affiliated Hospital of Gannan Medical University
ORCID:
0009-0005-0121-6326
Observed ORCID:
0009-0005-0121-6326
OpenAlex ID:
A5020797235
Mesenchymal stem cell-derived exosomes: an emerging therapeutic strategy for hepatic ischemia-reperfusion injury
2025
·
Bo Zhao
, Jiping Wei
, et al.
·
Stem Cell Research & Therapy
·
30
PDF
Progress of mesenchymal stem cells (MSCs) & MSC-Exosomes combined with drugs intervention in liver fibrosis
2024
·
Yan Xu
, Xiaolei Zhou
, et al.
·
Biomedicine & Pharmacotherapy
·
29
Luteolin mitigates renal ischemia-reperfusion injury via anti-inflammatory, anti-apoptotic, and Nrf2/HO-1-mediated antioxidant effects
2025
·
Ji-Ping Wei
, Bo Zhao
, et al.
·
European Journal of Pharmacology
·
18
Single and combined strategies for mesenchymal stem cell exosomes alleviate liver fibrosis: a systematic review and meta-analysis of preclinical animal models
2024
·
Xiaolei Zhou
, Yan Xu
, et al.
·
Frontiers in Pharmacology
·
14
PDF
Mesenchymal stem cell therapy for liver fibrosis need “partner”: Results based on a meta-analysis of preclinical studies
2024
·
Yan Xu
, Xue-Song Wang
, et al.
·
World Journal of Gastroenterology
·
7
S‐Nitrosylation of NOTCH1 Regulates Mesenchymal Stem Cells Differentiation Into Hepatocyte‐Like Cells by Inhibiting Notch Signalling Pathway
2024
·
Xuesong Wang
, Yan Xu
, et al.
·
Journal of Cellular and Molecular Medicine
·
4
PDF
Show more works
View as search
Works count:
6
Citation count:
102
H-index:
5
I10-index:
4
Year
Topic
Type
